(Houston, Texas, USA), evidence-based research has underlined the need for neuropsychological instruments in cognitive assessment. To date, however, the absence of neuropsychological expertise at cancer centers has limited the extent to which cognition can be thoroughly tested. An even greater challenge is to develop methods that evaluate and assemble different sources of clinical data.
To renew attention toward improving the quality of the neurological and cognitive examination, the editors of this special issue have put together a collection of articles by researchers and clinicians who presented their work at the meeting entitled ''Measuring clinical outcome in neurooncology: tools and parameters. To what extent can neuropsychology become part and parcel of clinical practice?'' (January 2011, Verona, Italy) and exchanged experience on research and assessment across multidisciplinary competences.
Building on the work started more than 30 years ago, the overarching aim is to achieve an international consensus on the core outcome set in neuro-oncology, now considering the patient-related counterpart. Balanced in scope, the topics covered here will capture the interest of all those involved in the fascinating task of combating cancer while preserving brain functioning. The original and review papers presented here outline the state of the art and indicate prospects for clinical research.
